GSDME and cancer: Indeed, utilizing the TCGA database, we validated the expression of GSDME across various cancers and found GSDME to be significantly down-regulated in bladder, breast, cervical, colon, renal clear cell, ovarian, prostate, endometrial, and uterine sarcoma cancers (Fig. 3C).